```html

Epiglottitis – A Comprehensive Medical Guide

Overview

Epiglottitis is a potentially life‑threatening inflammation of the epiglottis—the small, leaf‑shaped flap of cartilage at the base of the tongue that covers the windpipe during swallowing. When inflamed, the epiglottis can swell rapidly, obstructing the airway and causing severe breathing difficulty.

Although once common in children, the introduction of the Haemophilus influenzae type b (Hib) vaccine in the late 1980s shifted the epidemiology. Today, epiglottitis is more frequently seen in adolescents and adults, but it remains a medical emergency at any age.

Prevalence (global data, 2022):

• Incidence in children < 5 years: ~0.5–1 case per 100,000 per year in high‑income countries (down from ~10 cases/100,000 before Hib vaccination).<sup>CDC</sup>
• Incidence in adults: 1–4 cases per 100,000 annually, with a higher proportion of bacterial etiology other than Hib.<sup>Mayo Clinic</sup>
• Male-to-female ratio ≈ 1.5:1 in adults.<sup>NIH</sup>

Symptoms

Symptoms can develop suddenly within a few hours and progress quickly. The classic “tripod” posture—leaning forward with arms braced on the knees—may be observed as the patient tries to maximize airway patency.

Upper‑airway symptoms

• Sore throat: Often severe and disproportionate to visible oral findings.
• Odynophagia (painful swallowing): Leads to drooling because patients avoid opening the mouth.
• Stridor: High‑pitched, harsh sound on inspiration indicating airway narrowing.
• Hoarseness or muffled “hot‑dog” voice: Result of edema affecting the supraglottic structures.
• Respiratory distress: Rapid, shallow breathing, use of accessory muscles.

Systemic symptoms

• Fever (often >38.5 °C/101.3 °F).
• Chills, rigors.
• Generalized malaise, fatigue.
• Headache.

Late or severe signs

• Severe dyspnea with cyanosis.
• Silent or “gurgling” breathing.
• Altered mental status (confusion, lethargy) due to hypoxia.

Causes and Risk Factors

Infectious Etiology

• Haemophilus influenzae type b (Hib): Historically the most common cause in children.
• Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Streptococcus pyogenes – more common in adults.
• Viral agents: Rarely, influenza, parainfluenza, or herpes simplex virus can trigger secondary bacterial infection.

Non‑infectious Causes

• Thermal injury (inhalation of hot liquids or steam).
• Chemical irritation (acidic or alkaline fumes).
• Trauma from accidental foreign body ingestion.
• Allergic reactions (e.g., anaphylaxis involving the supraglottic area).

Risk Factors

• Age < 5 years without up‑to‑date Hib vaccination.
• Immunocompromised state (HIV/AIDS, chemotherapy, long‑term steroids).
• Recent upper‑respiratory infection.
• Chronic smoking or vaping, which damages mucosal immunity.
• Diabetes mellitus – impairs neutrophil function.
• Recent dental or ENT procedures that breach mucosal barriers.

Diagnosis

Clinical Evaluation

Because airway compromise can occur within minutes, the initial assessment focuses on securing the airway. A careful history (onset, fever, recent illness) and physical exam (look for drooling, tripod posture, stridor) guide urgency.

Imaging

• Lateral neck X‑ray: Classic “thumbprint sign” – an enlarged, rounded epiglottis.
• Soft‑tissue neck CT (with contrast): Provides detailed view of edema and rules out abscess; reserved for stable patients.

Endoscopic Examination

Direct visualization with a flexible nasopharyngoscope or laryngoscope confirms diagnosis and gauges severity. This should be performed in a controlled setting (operating room or intensive‑care unit) with preparation for immediate airway intervention.

Laboratory Tests

• Complete blood count (CBC) – usually shows leukocytosis.
• Blood cultures – positive in ~30 % of bacterial cases.
• Throat swab or epiglottic aspirate for culture/PCR to identify pathogen; however, sampling is often avoided until airway is secured.
• Inflammatory markers (CRP, ESR) – elevated but non‑specific.

Additional Tests

If a viral or atypical cause is suspected, viral PCR panels and serology may be ordered.

Treatment Options

Airway Management – First Priority

• Intubation: Endotracheal tube placement under controlled anesthesia in the operating room, using a video‑laryngoscope or fiber‑optic scope.
• Tracheostomy: Considered when intubation fails or edema persists despite medical therapy.
• Patients should be placed in a semi‑upright (45°) position to reduce airway obstruction.

Antimicrobial Therapy

Empiric broad‑spectrum antibiotics are started immediately after cultures are drawn.

Agent	Typical Dose (adult)	Coverage
Ceftriaxone 1‑2 g IV q24h	Broad‑spectrum β‑lactam
Vancomycin (adjusted for renal function) IV q12h	MRSA
Clindamycin 600 mg IV q8h	Anaerobes & toxin‑producing Strep

Once the pathogen is identified, therapy is narrowed (e.g., high‑dose penicillin for Hib, or oxacillin for MSSA).

Corticosteroids

Intravenous dexamethasone 0.6 mg/kg (max 10 mg) once daily is commonly used to reduce edema, although high‑quality evidence is limited. Many otolaryngology societies consider it adjunctive therapy.

Supportive Care

• Oxygen supplementation (nasal cannula or face mask) to maintain SpO₂ ≥ 94 %.
• IV fluids to prevent dehydration from poor oral intake.
• Analgesia (acetaminophen or ibuprofen) for fever and throat pain.
• Close monitoring in an intensive‑care unit (ICU) for at least 24–48 hours after airway stabilization.

Lifestyle / Adjunct Measures

• Humidified oxygen or nebulized saline can provide symptomatic relief.
• Strict bed rest while intubated; avoid activities that increase intra‑abdominal pressure (e.g., Valsalva).

Living with Epiglottitis

Post‑Hospital Recovery

• Most patients are discharged after 3‑5 days if the airway remains stable and fever resolves.
• Complete antibiotic course: 10‑14 days (IV then oral) as guided by culture.
• Follow‑up laryngoscopic exam 1‑2 weeks after discharge to confirm resolution of edema.

Practical Daily Management

• Hydration: Sip warm (not hot) fluids; avoid citrus or spicy foods that may irritate the throat.
• Voice rest: Limit talking for the first several days to reduce strain.
• Medication adherence: Finish the full antibiotic course even if symptoms improve.
• Activity: Gradual return to normal activities; avoid heavy exertion for 1 week after discharge.
• Monitoring: Keep a log of temperature, breathing difficulty, or new throat pain; contact a provider if worsening.

Psychosocial Considerations

Because the episode can be frightening, especially if intubation was required, patients may benefit from counseling or support groups for post‑intensive‑care syndrome.

Prevention

• Vaccination: The Hib vaccine series (3‑dose primary series + booster) provides >95 % protection against Hib epiglottitis. CDC
• Seasonal influenza vaccine: Reduces secondary bacterial superinfection.
• Good hand hygiene and respiratory etiquette: Limits spread of bacterial pathogens.
• Avoid smoking/vaping: Protects mucosal immunity of the upper airway.
• Prompt treatment of upper‑respiratory infections: Reduces bacterial overgrowth that can seed the epiglottis.
• Safe food and drink practices: Avoid scalding liquids and carefully chew food to prevent thermal or mechanical injury.

Complications

If airway obstruction is not rapidly managed, epiglottitis can be fatal within hours. Other potential complications include:

• Airway stenosis: Persistent scar tissue causing chronic breathing difficulty.
• Sepsis: Bacterial spread to bloodstream, especially with Hib or MRSA.
• Abscess formation: Sub‑epiglottic or peritonsillar abscess requiring surgical drainage.
• Vocal cord dysfunction: Long‑term hoarseness or dysphonia.
• Recurrent epiglottitis: Though rare, some individuals experience repeat episodes.

When to Seek Emergency Care

References

1. Mayo Clinic. Epiglottitis. https://www.mayoclinic.org/diseases-conditions/epiglottitis/symptoms-causes/syc-20351885 (accessed April 2026).
2. Centers for Disease Control and Prevention. Haemophilus influenzae type b (Hib) Vaccine. https://www.cdc.gov/hinfluenzae/hib/vaccine.html (accessed April 2026).
3. National Institutes of Health. Epiglottitis: Clinical Features and Management. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261618/ (2020).
4. World Health Organization. WHO Guidelines for the Management of Acute Upper Airway Infections. https://www.who.int/publications/i/item/WHO‑2023‑upper‑airway (2023).
5. Cleveland Clinic. Epiglottitis – Symptoms, Diagnosis, Treatment. https://my.clevelandclinic.org/health/diseases/16071-epiglottitis (accessed April 2026).
6. Johns Hopkins Medicine. Airway Management in Epiglottitis. https://www.hopkinsmedicine.org/health/conditions/epiglottitis (2022).

```